Ketonal DUO - Instructions For Use Of Capsules 150 Mg, Price, Reviews

Table of contents:

Ketonal DUO - Instructions For Use Of Capsules 150 Mg, Price, Reviews
Ketonal DUO - Instructions For Use Of Capsules 150 Mg, Price, Reviews

Video: Ketonal DUO - Instructions For Use Of Capsules 150 Mg, Price, Reviews

Video: Ketonal DUO - Instructions For Use Of Capsules 150 Mg, Price, Reviews
Video: Кетонал ДУО. Особенность лекарственной формы 2023, December

Ketonal DUO

Ketonal DUO: instructions for use and reviews

  1. 1. Release form and composition
  2. 2. Pharmacological properties
  3. 3. Indications for use
  4. 4. Contraindications
  5. 5. Method of application and dosage
  6. 6. Side effects
  7. 7. Overdose
  8. 8. Special instructions
  9. 9. Application during pregnancy and lactation
  10. 10. Use in childhood
  11. 11. In case of impaired renal function
  12. 12. For violations of liver function
  13. 13. Drug interactions
  14. 14. Analogs
  15. 15. Terms and conditions of storage
  16. 16. Terms of dispensing from pharmacies
  17. 17. Reviews
  18. 18. Price in pharmacies

Latin name: Ketonal DUO

ATX code: M01AE03

Active ingredient: ketoprofen (Ketoprophenum)

Manufacturer: Lek (Slovenia)

Description and photo update: 2018-22-10

Prices in pharmacies: from 199 rubles.


Modified release capsules Ketonal DUO
Modified release capsules Ketonal DUO

Ketonal DUO is a drug with analgesic, anti-inflammatory and antipyretic effects.

Release form and composition

Dosage form of release of Ketonal DUO - capsules with modified release: size No. 1; case - transparent, lid - blue; the capsules contain yellow and white pellets (10 pcs. in blisters, in a cardboard box 1-3 blisters).

Composition of 1 capsule:

  • active substance: ketoprofen - 150 mg;
  • auxiliary components: lactose monohydrate - 20 mg; croscarmellose sodium - 10 mg; povidone - 5 mg; microcrystalline cellulose - 34 mg; polysorbate-80 - 1 mg;
  • capsule shell: titanium dioxide (E 171) - 0.9%; indigo carmine (E 132) - 0.4%; gelatin - up to 100%;
  • pellet shell: colloidal silicon dioxide - 0.2 mg; talc - 0.2 and 1.760 mg; eudragit RL 30 D [copolymer of methyl methacrylate, ethyl acrylate and trimethylammonioethyl methacrylate (2: 1: 0.2)] - 4.908 mg; eudragit RS 30 D [copolymer of methyl methacrylate, ethyl acrylate and trimethylammonioethyl methacrylate (2: 1: 0.1)] - 4.908 mg; iron oxide (III) yellow (E 172) - 0.08 mg; triethyl citrate - 0.88 mg; polysorbate-80 - 0.008 mg.

Pharmacological properties


Ketonal DUO is a non-steroidal anti-inflammatory drug (NSAID). It has analgesic, antipyretic and anti-inflammatory effects.

Due to the inhibition of COX-1 and COX-2 (cyclooxygenase) and (partially) lipoxygenase, ketoprofen stabilizes lysosomal membranes and inhibits the synthesis of bradykinin and prostaglandins.

Ketoprofen does not have a negative effect on the articular cartilage.


Ketonal DUO is presented in a new dosage form, which differs from conventional capsules in a special release of the active substance. The capsules contain 2 types of pellets: about 60% of the total amount are white, the rest are yellow (coated). The active substance is released quickly from white pellets, and slowly from yellow ones. This provides a combination of prolonged and fast action.

After oral administration, Ketonal DUO is well absorbed.

Bioavailability of the substance in the form of conventional capsules / capsules with modified release is 90%.

Food intake has no effect on the total bioavailability (AUC) of ketoprofen, but the rate of absorption decreases. After oral administration of 150 mg of Ketonal DUO, Cmax (maximum concentration of the substance) in the blood plasma is achieved in 1.76 hours and is 9036.64 ng / ml.

99% of ketoprofen binds to plasma proteins (mainly albumin). The volume of distribution is 0.1–0.2 l / kg. The substance penetrates well into the synovial fluid and reaches 30% of the plasma concentration. Significant concentrations in the synovial fluid remain stable for up to 30 hours, as a result of which joint stiffness and pain syndrome decrease for a long time.

Ketoprofen, with the participation of microsomal liver enzymes, undergoes intensive metabolism. Binding occurs with glucuronic acid, excreted in the form of glucuronide. Ketoprofen has no active metabolites. The half-life is less than 2 hours.

Approximately 80% of ketoprofen is excreted in the urine, mainly (more than 90%) in the form of ketoprofen glucuronide, about 10% is excreted through the intestines.

The plasma concentration of ketoprofen in liver failure doubles (this is probably due to hypoalbuminemia and the associated high level of unbound active ketoprofen). For this group of patients, the drug should be prescribed in the minimum therapeutic dose.

In renal failure, ketoprofen clearance decreases, and dose adjustment is required.

Indications for use

Ketonal DUO 150 mg capsules are prescribed for the symptomatic treatment of inflammatory / painful processes of various etiologies, including:

  • diseases of the musculoskeletal system of inflammatory and degenerative etiology: rheumatoid arthritis, gout, pseudogout, seronegative arthritis (including psoriatic arthritis, ankylosing spondylitis, reactive arthritis), osteoarthritis;
  • pain syndrome: headache, algomenorrhea, neuralgia, tendinitis, myalgia, bursitis, sciatica, post-traumatic and postoperative pain, pain syndrome in cancer.



  • exacerbation of gastric ulcer and duodenal ulcer;
  • a history of rhinitis, bronchial asthma, urticaria associated with the intake of acetylsalicylic acid and other NSAIDs;
  • nonspecific ulcerative colitis,
  • exacerbation of inflammatory bowel disease;
  • exacerbation of Crohn's disease;
  • severe hepatic and (or) renal failure;
  • hemophilia and other blood clotting disorders;
  • decompensated heart failure;
  • progressive kidney disease;
  • postoperative period after coronary artery bypass grafting;
  • chronic dyspepsia;
  • cerebrovascular, gastrointestinal and other bleeding (including the presence of suspicion of them);
  • age up to 15 years;
  • III trimester of pregnancy and breastfeeding period;
  • individual intolerance to the components of the drug, as well as salicylates or other NSAIDs.

Relative (diseases / conditions in the presence of which the appointment of Ketonal DUO requires caution):

  • a history of peptic ulcer disease, gastrointestinal ulceration and bronchial asthma;
  • clinically significant cerebrovascular and cardiovascular diseases;
  • peripheral arterial disease;
  • progressive liver disease;
  • dyslipidemia;
  • hyperbilirubinemia;
  • chronic heart failure;
  • renal failure;
  • arterial hypertension;
  • diabetes;
  • blood diseases;
  • dehydration;
  • alcoholism;
  • smoking;
  • long-term use of NSAIDs;
  • concomitant use with the following drugs: anticoagulants (warfarin), antiplatelet agents (acetylsalicylic acid), oral glucocorticosteroids (prednisolone), selective serotonin reuptake inhibitors (sertraline, citalopram);
  • I – II trimesters of pregnancy.

Instructions for the use of Ketonal DUO: method and dosage

Capsules Ketonal DUO 150 mg are taken orally with water or milk (at least 100 ml), preferably during or after meals.

The standard dose is 1 capsule per day.

The maximum daily dose of ketoprofen is 200 mg.

Side effects

Possible adverse reactions (> 10% - very common;> 1% and 0.1% and 0.01% and <0.1% - rarely; <0.01% - very rare):

  • urinary system: rarely - impaired renal function, nephrotic syndrome, interstitial nephritis, hematuria (more often appears in patients taking diuretics and NSAIDs for a long time);
  • cardiovascular system: infrequently - peripheral edema, arterial hypertension, tachycardia;
  • central nervous system: often - nightmares, sleep disturbances, dizziness, headache, nervousness, fatigue; rarely - peripheral polyneuropathy, migraine; very rarely - speech disorder, disorientation, hallucinations;
  • digestive system: often - dyspepsia (in the form of nausea, diarrhea or constipation, flatulence, vomiting, decreased or increased appetite), stomatitis, abdominal pain, dry mouth; infrequently (with prolonged intake of high doses) - ulceration of the mucous membrane of the gastrointestinal tract, impaired hepatic function; rarely - perforation of the gastrointestinal tract, gastrointestinal bleeding, melena, transient increase in the level of liver enzymes, exacerbation of Crohn's disease;
  • hematopoietic system: reduced platelet aggregation; rarely - thrombocytopenia, anemia, purpura, agranulocytosis;
  • allergic reactions: often - skin reactions (in the form of itching, urticaria); infrequently - anaphylactoid reactions, shortness of breath, rhinitis, angioedema, bronchospasm;
  • sense organs: rarely - conjunctivitis, change in taste, tinnitus, blurred visual perception;
  • others: rarely - menometrorrhagia, hemoptysis.


The main symptoms are vomiting (including blood), seizures, respiratory depression, nausea, abdominal pain, melena, impaired consciousness, impaired renal function and renal failure.

Therapy: gastric lavage, intake of activated carbon; symptomatic treatment. The effect on the gastrointestinal tract can be mitigated by the use of prostaglandins, proton pump inhibitors, and histamine H2 receptor blockers.

special instructions

With prolonged therapy, monitoring of the state of the blood, as well as of the renal / hepatic function is required, especially in elderly patients.

Against the background of arterial hypertension and cardiovascular diseases, which can lead to fluid retention in the body, taking Ketonal DUO requires caution and more frequent blood pressure monitoring.

It must be taken into account that the drug can mask the signs of infectious diseases.

Influence on the ability to drive vehicles and complex mechanisms

When driving motor vehicles, it is necessary to take into account the patient's individual response to the therapy.

Application during pregnancy and lactation

  • III trimester of pregnancy, lactation period - taking Ketonal DUO is contraindicated;
  • I – II trimesters of pregnancy - therapy can be carried out with caution in cases where the expected benefit is greater than the potential harm.

Pediatric use

According to the instructions, Ketonal DUO is not assigned to children under 15 years of age.

With impaired renal function

Contraindication to taking Ketonal DUO is severe renal failure.

For violations of liver function

Contraindication to taking Ketonal DUO is severe hepatic failure.

Drug interactions

Possible interactions:

  • diuretics and antihypertensive drugs: weakening their action;
  • other NSAIDs, salicylates, glucocorticosteroids, ethanol: an increase in the likelihood of adverse events from the digestive system;
  • oral hypoglycemic and some anticonvulsants (phenytoin): increasing their action;
  • mifepristone: decrease in its effectiveness (you should not start taking Ketonal DUO earlier than 8-12 days after discontinuation of mifepristone);
  • anticoagulants, thrombolytics, antiplatelet agents: an increase in the likelihood of bleeding;
  • cardiac glycosides, blockers of slow calcium channels, lithium preparations, cyclosporine, methotrexate: an increase in their plasma concentration;
  • diuretics or angiotensin-converting enzyme inhibitors: increased risk of impaired renal function.


Analogs of Ketonal DUO are Arketal Rompharm, Fastum gel, Valusal, Bystrumgel, Flamax, Bystrumcaps, Artrozilen, Ketonal, OKI, Artrum, Febrofid, Pentalgin, Flexen, Ketoprofen, etc.

Terms and conditions of storage

Store in a place protected from light at temperatures up to 25 ° C. Keep out of the reach of children.

Shelf life is 2 years.

Terms of dispensing from pharmacies

Dispensed by prescription.

Reviews about Ketonal DUO

According to reviews, Ketonal DUO is an effective drug with a long-term analgesic effect. Of the shortcomings, they most often indicate the development of pronounced side effects and high cost. There are also reviews that note the lack of a therapeutic effect.

Price for Ketonal DUO in pharmacies

The approximate price for Ketonal DUO (20 or 30 pieces per pack) is 90–240 or 210–255 rubles.

Ketonal DUO: prices in online pharmacies

Drug name



Ketonal DUO 150 mg modified release capsules 30 pcs.

199 RUB


Ketonal DUO capsules with modif. release 150mg 30 pcs. Lek

RUB 218


Maria Kulkes
Maria Kulkes

Maria Kulkes Medical journalist About the author

Education: First Moscow State Medical University named after I. M. Sechenov, specialty "General Medicine".

Information about the drug is generalized, provided for informational purposes only and does not replace the official instructions. Self-medication is hazardous to health!